Session Description and Objectives
- Autoimmune treatment remains inefficient: in search of sustained response, patients may spend years if not decades cycling through the treatment options available for their disease-label
- While disease-label-based assessments are conventional, the underlying immune processes can be viewed as a shared mechanistic system, under which different perturbations can result in autoimmune-driven symptoms, with substantial symptom overlap across those disease-labels
- This presentation describes a disease-label-agnostic framework combining mechanistic quantitative systems pharmacology (QSP) modeling with interpretable machine learning to derive biomarker-based precision medicine treatment-assignment rules
- Describe how a disease-label-agnostic autoimmune QSP framework can be combined with interpretable machine learning to guide precision medicine therapy-assignment
- Describe applications of the framework
- Describe benefits of the paradigm shift in thinking that the application suggests
By Noah Brostoff
AAPS PharmSci 360 2026, October 25-28, 2026, New Orleans, Louisiana